Vattenfall AB Feb 10

  • ID: 2026706
  • February 2010
  • Standard & Poors
1 of 3

Strong position in the northern European electricity market. Large and diverse operations. Competitive generation portfolio. Prudent trading and hedging policies. Significant share of stable, regulated and monopoly-like operations. Weakened financial profile following a large debt-funded acquisition in a difficult market environment. Exposure to competitive markets and volatile electricity prices. Operating risk of nuclear operations. Significant capital expenditure program. The ratings on Swedish-based power utility Vattenfall AB reflect its strong position in the northern European electricity market, large and diverse operations, and competitive generation portfolio. In addition, Vattenfall generates relatively stable cash flow from electricity distribution and heating operations. These strengths are balanced by Vattenfall's exposure to competition and price volatility in power generation, risks related to nuclear and coal-fired generation,...

Companies mentioned in this report are:
- Vattenfall AB

Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Vattenfall AB

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.